Ascendis Pharma A ASND
NASDAQ ASND
$227.83 -0.24 (-0.11%)
At close: Sep 30, 2026 · 4:00 PM EDT

Ascendis Pharma A (ASND) Other Non-Current Liabilities (2019 - 2026)

Updated

Ascendis Pharma A (ASND) recorded Other Non-Current Liabilities of $68.22 million in the quarter ended Jun 30, 2026, up 51.0% from $45.19 million a year earlier and up 1.7% from the prior quarter.

Analysis

Ascendis Pharma A (ASND) Other Non-Current Liabilities (2019 - 2026) Analysis & Trends

As of Dec 31, 2025, Ascendis Pharma A reported Other Non-Current Liabilities of $65.76 million, down 10.6% from the prior year.

  • Annual Other Non-Current Liabilities has a five-year compound annual growth rate of 77.1% (years ended Dec 2020 to Dec 2025).
  • Across earlier years, Other Non-Current Liabilities came in at $73.55 million in the year ended Dec 31, 2024 (+65.1%), $44.54 million in the year ended Dec 31, 2023 (+32.1%), $33.71 million in the year ended Dec 31, 2022 (-1.6%) and $34.26 million in the year ended Dec 31, 2021 (+808.9%).
  • The figure for the quarter ended Jun 30, 2026 is the highest quarterly Other Non-Current Liabilities since the quarter ended Dec 31, 2024.
  • On a year-over-year basis, Other Non-Current Liabilities rose in seven of the last eight quarters, with growth averaging 43.2%.
  • Peak year-over-year performance for Other Non-Current Liabilities in the last five years was growth of 808.9% in the quarter ended Dec 31, 2021, against a decline of 6.7% in the quarter ended Dec 31, 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $67.1 million (quarter ended Mar 31, 2026), $67.75 million (quarter ended Dec 31, 2025) and $56.46 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Ascendis Pharma A 14.12 Bn 10.37 Bn 362.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 68.22 Mn
Mar 31, 2026 67.10 Mn
Dec 31, 2025 67.75 Mn
Sep 30, 2025 56.46 Mn
Jun 30, 2025 45.19 Mn
Mar 31, 2025 40.04 Mn
Dec 31, 2024 72.62 Mn
Sep 30, 2024 46.39 Mn
Jun 30, 2024 28.44 Mn
Mar 31, 2024 24.66 Mn
Dec 31, 2023 44.30 Mn
Sep 30, 2023 36.64 Mn
Jun 30, 2023 24.89 Mn
Mar 31, 2023 16.64 Mn
Dec 31, 2022 32.64 Mn
Sep 30, 2022 26.80 Mn
Jun 30, 2022 22.36 Mn
Mar 31, 2022 14.07 Mn
Dec 31, 2021 34.26 Mn
Dec 31, 2020 3.77 Mn
API Access

Ascendis Pharma A Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=ASND&period=max&api_key=YOUR_API_KEY